Abstract
We previously demonstrated that bcl-2 over-expression increases the malignant behaviour of the MCF7 ADR human breast cancer cell line and enhances nuclear factor-kappa B (NF-kB) transcriptional activity. Here, we investigated the direct effect of increased NF-kB activity on the tumorigenicity of MCF7 ADR cells by over-expressing the NF-kB subunit relA/p65. Surprisingly, our results demonstrated that over-expression of relA determines a considerable reduction of the tumorigenic ability in nude mice as indicated by the tumour take and the median time of tumour appearance. In vitro studies also evidenced a reduced cell proliferation and the activation of the apoptotic programme after relA over-expression. Apoptosis was associated with the production of reactive oxygen species, and the cleavage of the specific substrate Poly-ADP-ribose-polymerrase. Our data indicate that there is no general role for NF-kB in the regulation of apoptosis and tumorigenicity. In fact, even though inhibiting NF-kB activity has been reported to be lethal to tumour cells, our findings clearly suggest that an over-induction of nuclear NF-kB activity may produce the same effect. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Abbadie C, Kabrun N, Bouali F, Smardova J, Stéhelin D, Vandenbunder B and Enrietto PJ (1993) High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro. Cell 75: 899–912
Andela VB, Schwarz EM, Puzas JE, O’Keefe RJ and Rosier RN (2000) Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor κB. Cancer Res 60: 6557–6562
Arlt A, Grobe O, Sieke A, Kruse M-L, Fölsch UR, Schmidt WE and Schäfer H (2001) Expression of the NF-kB target gene IEX-1 (p22/PRG1) does not prevent cell death but instead triggers apoptosis in Hela cells. Oncogene 20: 69–76
Baeuerle P and Henkel T (1994) Function and activation of NF-kB in the immune system. Annu Rev Immunol 12: 141–179
Baeuerle PA and Baltimore D (1996) NF-kappa B: ten years after. Cell 87: 13–20
Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W, Royer HD, Grinstein E, Greiner A, Scheidereit C and Dörken B (1997) Constitutive nuclear factor-κB-relA activation is required for proliferation and survival of Hodgkin’s disease tumor cells. J Clin Invest 100: 2961–2969
Bash J, Zong W-X and Gélinas C (1997) c-rel arrests the proliferation of HeLa cells and affects critical regulators of the G1/S-phase transition. Mol Cell Biol 17: 6526–6536
Biroccio A, Del Bufalo D, Ricca A, D’Angelo C, D’Orazi G, Sacchi A, Soddu S and Zupi G (1999) Increase of BCNU sensitivity by wt-p53 gene therapy in glioblastoma lines depends on the administration schedule. Gene Therapy 6: 1064–1072
Biroccio A, Candiloro A, Mottolese M, Sapora O, Albini A, Zupi G and Del Bufalo D (2000) Bcl-2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression and in vivo angiogenesis in a breast carcinoma line. Faseb J 14: 652–660
Blandino G, Levine AJ and Oren M (1999) Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy. Oncogene 18: 477–485
Carter BD, Kaltschmidt C, Kaltschmidt B, Offenhauser N, Bohm Matthaei R, Baeuerle PA and Barde YA (1996) Selective activation of NF-kappaB by nerve growth factor through the neurotrophin receptor p75. Science 272: 542–545
Del Bufalo D, Biroccio A, Soddu S, Laudonio N, D’Angelo C, Sacchi A and Zupi G (1996) Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene. J Clin Invest 98: 1165–1173
Del Bufalo D, Biroccio A, Leonetti C and Zupi G (1997) Bcl-2 overexpression enhances the metastatic potential of a human breast cancer line. Faseb J 11: 947–953
Dumont A, Hehner SP, Hofmann TG, Ueffing M, Dröge W and Schmitz ML (1999) Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-kB. Oncogene 18: 747–757
Gilmore TD (1997) Clinically relevant findings. J Clin Invest 100: 2935–2936
Grilli M and Memo M (1999) Nuclear factor kappa B/Rel proteins: a point of convergence of signaling pathways relevant in neuronal function and dysfunction. Biochem Pharmacol 57: 1–7
Grilli M, Pizzi M, Memorandum M and Spano P (1996) Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science 274: 1383–1385
Grimm S, Bauer MK, Baeuerle PA and Schulze Osthoff K (1996) Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis. J Cell Biol 134: 13–23
Higgins KA, Perez JR, Coleman TA, Dorshkind K, McComas WA, Sarmiento UM, Rosen CA and Narayanan R (1993) Antisense inhibition of the p65 subunit of NF-kB blocks tumorigenicity and causes tumour regression. Proc Natl Acad Sci USA 90: 9901–9905
Huang S, DeGuzman A, Bucana CD and Fidler IJ (2000) Nuclear factor-κB activity correlAtes with growth, angiogenesis, and metastasis of human melanoma cells in nude mice. Clinical Cancer Res 6: 2573–2581
Kaltschmidt B, Kaltschmidt C, Hofmann TG, Hehner SP, Dröge W and Schmitz ML (2000) The pro- or anti apoptotic function of NF-kB is determined be the nature of the apoptotic stimulus. Eur J Biochem 267: 3828–3835
Khaled Z, Benimetskaya L, Zeltser R, Khan T, Sharma HW, Narayanan R and Stein CA (1996) Multiple mechanisms may contribute to the cellular anti-adhesive effects of phosphorothioate oligodeoxynucleotides. Nucleic Acid Res 24: 737–745
Kitajima I, Shinohara T, Bilakovics J, Brown DA, Xu X and Nerenberg M (1992) Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-kappa B. Science 258: 1792–1795
Krappmann D, Emmerich F, Kordes U, Scharschmidt E, Dörken B and Scheidereit C (1999) Molecular mechanisms of constitutive NF-kB/Rel activation in Hodgkin/Reed-Sternberg cells. Oncogene 18: 943–953
Kroemer G, Zamzami N and Susin SA (1997) Mitochondrial control of apoptosis. Immun. Today 18: 45–51
Leonetti C, Biroccio A, Candiloro A, Citro G, Fornari C, Mottolese M, Del Bufalo D and Zupi G (1999) Increase of cisplatin sensitivity by c-myc antisense ologodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin. Clinical Cancer Res 5: 2588–2595
Lin B, Williams-Skipp C, Tao Y, Schleicher MS, Cano LL, Duke RC and Scheinman RI (1999) NF-kB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type. Cell Death Diff 6: 570–582
Lin K-I, Lee S-H, Narayanan R, Baraban JM, Hardwick JM and Ratan RR (1995) Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kB. J Cell Biol 131: 1149–1161
Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ Jr. and Sledge GW Jr. (1997) Constitutive activation of NK-κB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 17: 3629–3639
Pahl HL (1999) Activators and target genes of Rel/NF-kB transcription factors. Oncogene 18: 6853–6866
Polyak K, Xia Y, Zweier JL, Kinzler KW and Vogelstein B (1997) A model for p53-induced apoptosis. Nature 389: 300–305
Rayet B and Gélinas C (1999) Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18: 6938–6947
Ricca A, Biroccio A, Del Bufalo D, Mackay AR, Santoni A and Cippitelli M (2000) Bcl-2 overexpression enhances NF-kB activity and induces MMP-9 transcription in human MCF7ADR breast cancer cells. Int J Cancer 86: 188–196
Seitz CS, Lin Q, Deng H and Khavari PA (1998) Alterations in NF-kB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kB. Proc Natl Acad Sci USA 95: 2307–2312
Sheehy AM and Schlissel MS (1999) Overexpression of relA causes G1 arrest and apoptosis in a pro-B cell line. J Biol Chem 274: 8708–8716
Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM and Sonenshein GE (1997) Aberrant nuclear factor-κ/Rel expression and the pathogenesis of breast cancer. J Clin Invest 100: 2952–2960
Thanos D and Maniatis T (1999) NF-kB: a lesson in family values. Cell 80: 529–532
Visconti R, Cerutti J, Battista S, Fedele M, Trapasso F, Zeki K, Miano MP, de Nigris F, Casalino L, Curcio F, Santoro M and Fusco A (1997) Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NF-kB p65 protein expression. Oncogene 15: 1987–1994
Wang CY, Mayo MW, Korneluk RG, Goeddel DV and Baldwin AS Jr. (1998) NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281: 1680–1683
Wu H and Lozano G (1994) NF-kappaB activation of p53. A potential mechanism for suppressing cell growth in response to stress. J Biol Chem 269: 20067–20074
Wu MX, Ao Z, Prasad KV, Wu R and Schlossman SF (1998) IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival. Science 281: 998–1001
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Ricca, A., Biroccio, A., Trisciuoglio, D. et al. relA over-expression reduces tumorigenicity and activates apoptosis in human cancer cells. Br J Cancer 85, 1914–1921 (2001). https://doi.org/10.1054/bjoc.2001.2174
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.2174
Keywords
This article is cited by
-
Sam68 is a druggable vulnerability point in cancer stem cells
Cancer and Metastasis Reviews (2023)
-
Evaluation of chemo-preventive efficacy of Ficus religiosa latex extract by flow cytometry analysis and gene expression studies performed by RT-PCR in various cell lines
Future Journal of Pharmaceutical Sciences (2021)
-
Sustained, neuron-specific IKK/NF-κB activation generates a selective neuroinflammatory response promoting local neurodegeneration with aging
Molecular Neurodegeneration (2013)
-
Overexpression of p65 attenuates celecoxib-induced cell death in MDA-MB-231 human breast cancer cell line
Cancer Cell International (2013)
-
Nucleolar NF-κB/RelA mediates apoptosis by causing cytoplasmic relocalization of nucleophosmin
Cell Death & Differentiation (2011)